DENISCHEMPharmaceuticals
Denis Chem Lab Ltd — Cash Flow Statement
₹56.54
-4.91%
Denis Chem Lab Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 4.46 Cr | 10.89 Cr | 11.64 Cr | 11.58 Cr | — |
| Capital Expenditure | -7.63 Cr | -6.93 Cr | -4.70 Cr | -5.49 Cr | — |
| End Cash Position | 0.85 Cr | 1.19 Cr | 2.48 Cr | 1.30 Cr | — |
| Beginning Cash Position | 1.19 Cr | 2.48 Cr | 1.30 Cr | 1.57 Cr | — |
| Changes In Cash | -0.34 Cr | -1.29 Cr | 1.18 Cr | -0.27 Cr | — |
| Financing Cash Flow | -4.21 Cr | -4.21 Cr | -4.01 Cr | -7.20 Cr | — |
| Interest Paid Cff | -0.51 Cr | -0.54 Cr | -0.64 Cr | -0.76 Cr | — |
| Cash Dividends Paid | -3.47 Cr | -2.78 Cr | -2.08 Cr | -1.04 Cr | — |
| Net Issuance Payments Of Debt | -0.23 Cr | -0.89 Cr | -1.28 Cr | -5.40 Cr | — |
| Net Short Term Debt Issuance | -0.23 Cr | -0.42 Cr | -0.03 Cr | -4.08 Cr | — |
| Net Long Term Debt Issuance | 14000.00 | -0.47 Cr | -1.26 Cr | -1.33 Cr | — |
| Investing Cash Flow | -8.23 Cr | -14.89 Cr | -11.15 Cr | -10.14 Cr | — |
| Interest Received Cfi | 0.83 Cr | 1.06 Cr | 0.47 Cr | 0.19 Cr | — |
| Net Investment Purchase And Sale | -1.43 Cr | -9.03 Cr | -6.92 Cr | -4.94 Cr | — |
| Capital Expenditure Reported | -7.63 Cr | -6.93 Cr | -4.70 Cr | -5.49 Cr | — |
| Operating Cash Flow | 12.09 Cr | 17.81 Cr | 16.34 Cr | 17.07 Cr | — |
| Taxes Refund Paid | -4.89 Cr | -4.34 Cr | -2.39 Cr | -1.08 Cr | — |
| Change In Working Capital | 0.16 Cr | 1.18 Cr | -0.22 Cr | 3.36 Cr | — |
| Change In Other Current Liabilities | 0.78 Cr | -0.62 Cr | 0.18 Cr | -0.04 Cr | — |
| Change In Other Current Assets | -1.49 Cr | -0.44 Cr | 0.42 Cr | -0.11 Cr | — |
| Change In Payable | -0.17 Cr | 3.13 Cr | -1.42 Cr | 4.03 Cr | — |
| Change In Inventory | 0.38 Cr | -1.07 Cr | 0.77 Cr | -0.78 Cr | — |
| Change In Receivables | 1.04 Cr | -0.42 Cr | 0.60 Cr | 1.04 Cr | — |
| Other Non Cash Items | -1.33 Cr | -0.73 Cr | 0.17 Cr | 0.56 Cr | — |
| Depreciation And Amortization | 6.86 Cr | 6.95 Cr | 7.82 Cr | 5.76 Cr | — |
| Depreciation | 6.86 Cr | 6.95 Cr | 7.82 Cr | 5.68 Cr | — |
| Pension And Employee Benefit Expense | 0.18 Cr | -0.37 Cr | 0.05 Cr | -0.38 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income From Continuing Operations | 11.11 Cr | 15.13 Cr | 10.92 Cr | 8.88 Cr | — |
| Net Other Financing Charges | — | -1000.00 | — | 1000.00 | — |
| Provisionand Write Offof Assets | — | 0.00 | 0.00 | 0.00 | -0.16 Cr |
| Repayment Of Debt | — | — | -1.28 Cr | -5.40 Cr | -3.95 Cr |
| Other Cash Adjustment Outside Changein Cash | — | — | -1000.00 | -2000.00 | 1.00 |
| Short Term Debt Payments | — | — | -0.03 Cr | -4.08 Cr | -3.65 Cr |
| Long Term Debt Payments | — | — | -1.26 Cr | -1.33 Cr | -0.30 Cr |
| Net Other Investing Changes | — | — | -6.92 Cr | 0.11 Cr | 0.10 Cr |
| Amortization Cash Flow | — | — | 0.06 Cr | 0.08 Cr | 0.02 Cr |
| Gain Loss On Investment Securities | — | — | — | -0.03 Cr | — |
| Gain Loss On Sale Of PPE | — | — | — | -0.03 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Denis Chem Lab Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.